Trial intelligence / Profile preview

Effectiveness of Yoga Compared to Amantadine and Commitment Group Therapy in Multiple Sclerosis

IRCT20200423047176N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of amantadine in multiple sclerosis (MS) (3 arms), sponsored by Islamic Azad University. Started Apr 2020; status: completed.

02

Drugs

amantadine
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on IRCT20200423047176N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200423047176N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call